Search for: "COPE v. COPE"
Results 361 - 380
of 922
Sorted by Relevance
|
Sort by Date
24 Nov 2009, 8:20 pm
Co. v. [read post]
28 Jul 2018, 1:35 am
Grieving after Wrongful Death I’m Ed Smith, a Vacaville wrongful death lawyer. [read post]
25 Jun 2015, 3:02 pm
With the Supreme Court’s much anticipated June 25, 2015 King v. [read post]
9 Oct 2014, 8:46 am
The only old relist we’re aware of from OT2013 is Cope v. [read post]
10 Feb 2012, 7:23 am
Pecina v. [read post]
13 Aug 2013, 4:15 pm
But that ruling, in Marks v. [read post]
22 Nov 2013, 10:43 am
Sheehan v. [read post]
24 Jan 2016, 11:23 am
Prosecutors said they had no constitutional duty under Brady v. [read post]
8 Sep 2020, 4:45 pm
There's a lot to be said for Justice Streeter's partial dissent in this case. [read post]
16 Sep 2020, 6:15 am
See Vera v. [read post]
27 Sep 2023, 2:53 pm
See Mayo v. [read post]
30 Dec 2010, 9:10 am
The fact that MPAC was understaffed and unable to cope with a deluge of new condos on the market was no justification for using a two-stage assessment not expressly permitted by the Assessment Act, s.33(1). #5 -- Metropolitan Toronto Condominium Corporation No. 675 v. [read post]
14 Oct 2024, 6:24 am
National vaccine attorney Leah V. [read post]
17 Jun 2009, 3:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Gene patenting debate continues: UCLA v USPTO (Patent Docs) (Patent Docs) (PatentlyBIOtech) (Patent Docs) (IP Watchdog) US: FTC issues highly anticipated report on follow-on biologics; report concludes that special legislative exclusivity incentives are largely unwarranted for innovators and generics (FDA Law Blog) (Patent Docs) (Patent… [read post]
17 Jun 2009, 3:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Gene patenting debate continues: UCLA v USPTO (Patent Docs) (Patent Docs) (PatentlyBIOtech) (Patent Docs) (IP Watchdog) US: FTC issues highly anticipated report on follow-on biologics; report concludes that special legislative exclusivity incentives are largely unwarranted for innovators and generics (FDA Law Blog) (Patent Docs)… [read post]
21 Jun 2011, 5:00 am
June 20, 2011), and the class action case, Wal-Mart Stores, Inc. v. [read post]
21 Nov 2022, 5:42 am
The Law Offices of Leah V. [read post]
12 Sep 2017, 9:51 pm
The case, Alasaad v. [read post]
8 Feb 2015, 9:23 am
In particular they don’t recognise that particular patent strategies need to be adopted based on the scenario they are in, for example early stage v. late stage, academic tech transfer v. secretive long-term development, and collaborative v. independent research. [read post]
26 Apr 2015, 6:14 pm
The problem solution approach normally copes admirably under these conditions, but such proceedings too often seem to be deciding the fate of huge amounts of research based on a fortuitous interpretation of a paragraph in the patent specification or in the prior art. [read post]
